SEC Action Highlights Risks of Undisclosed Fees and Advisor Misconduct The U.S. Securities and Exchange Commission has filed charges against Florida-based investment advisor Kyle Asman, alleging a scheme that resulted in more than $500,000 in improper gains at the expense of investors. According to the SEC’s complaint, Asman, through his involvement with Backswing Ventures, allegedly [...]

Investors Who Purchased CORCEPT Stock May Have Limited Time to Act Investors who purchased shares of Corcept Therapeutics Incorporated may have only days remaining to take action as a key deadline approaches in a pending securities fraud class action. According to recently filed litigation, the case alleges that Corcept and certain executives made materially misleading [...]

Federal Regulators Are Sounding the Alarm on Trust-Based Investment Fraud The U.S. Securities and Exchange Commission (SEC) has issued a new investor alert warning of a sharp rise in relationship-based scams and impersonation fraud — two of the most psychologically sophisticated tactics being deployed against investors today (https://changeflow.com/govping/securities-markets/sec-bulletin-warns-of-relationship-scams-impersonation-fraud-2026-03-31). These are not opportunistic crimes. They are [...]

Overview The U.S. Securities and Exchange Commission (SEC) has charged David Gentile, founder and CEO of GPB Capital Holdings, in connection with an alleged $1.8 billion private fund fraud scheme that impacted thousands of investors nationwide. According to regulators, GPB Capital raised funds through private placement investments often sold through traditional brokerage firms and marketed [...]